Cytodyn Inc (CYDY)

[misiu143]

Study in Brazil should start to enroll in June , hospitals are getting ready ..lot of legal things must be first done,
so hopefully they be ready for June..

There will be 2 studies CD16 and CD17 ,
one for critical and much bigger for severe ..

Interim will be done at 40% , so I believe our company said , good chance to have it around August in critical..

And some countries are waiting for this interim results to see .

And looking at our CD12 , we expecting excellent results..

IN CD12 , patients were injected at 0 and and at 7 days , FDA refused to allow our study to have 4 weeks treatment,

But lets look at mortality benefits in CD12 critical patients ..

Day 7 -- 78%.
Day 14 -- 82%
Day 21-- 50%
Day 28 --31%

It is clearly needing 3 and 4 week of treatment , Why did FDA not allow us to have 4 weeks treatment , when doctors asked them ,
why when Dr Lalezari asked many times with interim result to look for that ..DSMC said all is FINE.

ALL WAS NOT FINE.Patients needed 2 more weeks of treatment.

In Brazil study will be with 4 weeks of treatment , and even possible first dose IV , this will be perfect.

Results should be excellent.

And ALL IMO.